Eli Lilly & Company (NYSE: LLY)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $839.87
-
Support level$803.58
-
Resistance levelN/A
-
Beta0.7
-
RSI (14-day)71.4
- LLY is one of this month's top performers with a return of 15.5 percent, beating 90 percent of stocks in the S&P-100.
- Up 15.9 percent, LLY is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- LLY is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, LLY is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
- Price crossed above 50-day moving average this week - a bullish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$625.65 | $932.06 | 73.9% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$783.89 | $736.35 | $760.05 | $765.76 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week8.6%
-
In the next month18.1%
-
In the next year77.6%
Period | Value |
---|---|
Historical (5 year) | 32.2% |
Last month | 30.6% |
Current estimate | 31.5% |
Next month forecast | 32.0% |